Transferable anticancer innate immunity in spontaneous regression/complete resistance mice
- 16 May 2006
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (20) , 7753-7758
- https://doi.org/10.1073/pnas.0602382103
Abstract
Spontaneous regression/complete resistance (SR/CR) mice resist very high doses of cancer cells that are lethal to WT mice even at low doses. In this study, we show that this resistance is mediated by rapid infiltration of leukocytes, mostly of innate immunity, in both primary and repeated challenges. Formation of rosettes with infiltrating natural killer cells, neutrophils, and macrophages was required for the subsequent destruction of cancer cells through rapid cytolysis. Highly purified natural killer cells, macrophages, and neutrophils from the SR/CR mice independently killed cancer cellsin vitro. The independent killing activity by each subset of effector cells is consistent with the observation that the resistance was abolished by depleting total infiltrating leukocytes but not by depleting only one or two subsets of leukocytes. The resistance was completely transferable to WT recipient mice through SR/CR splenocytes, bone marrow cells, or enriched peritoneal macrophages, either for prevention against subsequent cancer challenges or eradication of established malignancy at distant sites.Keywords
This publication has 20 references indexed in Scilit:
- Generation of tumor-specific T-cell therapiesBlood Reviews, 2006
- Exploitation of alloreactive NK cells in adoptive immunotherapy of cancerCurrent Opinion in Immunology, 2005
- Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic stem cell transplantationBest Practice & Research Clinical Haematology, 2004
- Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic stem cell transplantationBest Practice & Research Clinical Haematology, 2004
- Adoptive T-cell therapy for the treatment of solid tumoursExpert Opinion on Biological Therapy, 2002
- Current status of adoptive immunotherapy of cancerCritical Reviews in Oncology/Hematology, 1996
- Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody.The Journal of Experimental Medicine, 1994
- RAG-1-deficient mice have no mature B and T lymphocytesCell, 1992
- Immunologic and genetic characterization of S180, a cell line of murine origin capable of growing in different inbred strains of miceVeterinary Immunology and Immunopathology, 1992
- Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells.The Journal of Experimental Medicine, 1992